Project Grant R35GM163534
- Federal Grant Award Summary The University of California, San Diego received a $423,975 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award supports fundamental research focused on the discovery and application of halogenases—enzymes capable of installing halogen atoms (fluorine, chlorine, bromine, and iodine) onto organic compounds...
- Federal Grant Award Summary The University of California, San Diego received a $347,086 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award funds a five-year research initiative focused on developing precision, functional glyconanoassemblies through supramolecular design. The research aims to advance synthetic glycan assembly...
- Federal Project Grant Award Summary The University of California, San Diego (UCSD) received a $638,334 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 8, 2025, with a completion date of August 31, 2027. The award funds development of innovative computational drug design technologies through novel methods for thermodynamic mapping of proteins, ligands, and aqueous...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded UC San Diego a $150,104 Project Grant effective March 1, 2026, through December 31, 2028, under the Biomedical Research and Research Training program (CFDA 93.859). The award funds de novo design of artificial haloperoxidase enzymes, a fundamental research initiative aimed at advancing understanding of protein structure-function relationships and metalloenzyme design. The research will leverage...
- Federal Grant Award Summary The University of California, San Diego received a $370,550 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through February 28, 2031. This award funds the development of the Intracellular Protein Organization Landscape (IPOL), a quantitative computational framework designed to characterize and define cell types and states based on spatial...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $1.453 million under the Biomedical Research and Research Training program (CFDA 93.859) to The Regents of the University of California, San Francisco for a five-year research project running from September 5, 2025 through May 31, 2030. The research initiative, titled "Bridging the Gap Between Prediction and Reality in Structural Biology," focuses on developing advanced tools,...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded $150,104 to The Regents of the University of California, San Francisco on August 8, 2026, to support fundamental research in protein design and intramolecular signal transduction. The research deliverable involves the de novo design of allosterically regulated proteins that can undergo controlled conformational changes in...
- Federal Grant Award Summary The University of California, San Diego received a Project Grant award of $376,498 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, with a completion date of July 31, 2030. The award funds research into active genetic systems—CRISPR-based genetic technologies that bypass traditional inheritance patterns to enable self-propagating genetic elements known...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $562,484 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) for a five-year period from May 1, 2026, through April 30, 2031. This award supports the development of next-generation visualization and analysis software tools designed to enable scientific discovery in biomedical research. The project...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, San Francisco a Project Grant totaling $124,767 under the Biomedical Research and Research Training program (CFDA 93.859) to support de novo protein design research. The award, effective May 1, 2026, through April 30, 2028, funds investigation into protein dynamics and their contribution to enhanced enzymatic rates in computationally designed proteins. The research...
The University of California, San Diego received a $369,347 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026 through June 30, 2031. This award supports high-resolution structural analysis of megasynthases using cryo-electron microscopy (cryo-EM). The research focuses on developing and applying molecular tools and probes to capture state-trapped configurations of large Type I multimodular megasynthases, enabling previously unattainable high-resolution structures of these complex enzyme complexes involved in polyketide synthase and non-ribosomal peptide synthetase pathways. The project deliverables include the expansion of existing probes and technologies for structural elucidation of megasynthases that produce clinically important natural products, with initial focus on amphotericin B and cyclosporine A biosynthetic pathways. By unraveling the structural complexity of these carrier protein-dependent multienzyme systems, the research is intended to provide unprecedented molecular visualization of protein-protein interactions and enable the development of designed metabolic pathways with applications across infectious disease, metabolic, immunomodulatory, and oncological drug discovery and development.Summary of Federal Grant Award
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $369.3k | 6/10/26 |